Results 41 to 50 of about 602,989 (338)
Headache, 2020 Objective To examine the influences of depression and anxiety on headache‐related disability in people with episodic migraine or chronic migraine. Background Depression and anxiety are common comorbidities in people with migraine, especially among those ...
R. Lipton +6 more
semanticscholar +1 more source
Real world preventative drug management of migraine among Spanish neurologists
The Journal of Headache and Pain, 2019 Background Many different preventatives have showed efficacy in the treatment of migraine. National guidelines differ in their recommendations and patients’ characteristics are usually taken into account in their selection.
D. García-Azorin +4 more
doaj +1 more source
The Journal of Headache and Pain, 2020 Introduction Headache is one of the most frequent neurologic manifestations in COVID-19. We aimed to analyze which symptoms and laboratory abnormalities were associated with the presence of headache and to evaluate if patients with headache had a higher ...
J. Trigo +17 more
semanticscholar +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Introduction The kappa‐free light chain (κ‐FLC) index is known to be highly sensitive and specific for diagnosing multiple sclerosis (MS), while little is understood about lambda (λ)‐FLC. This study assessed the κ‐FLC and λ‐FLC indices in autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy.
Michael Levraut +11 more
wiley +1 more source
COVID‐19 and Headache: A Primer for Trainees
Headache, 2020 Objective To summarize for the trainee audience the possible mechanisms of headache in patients with COVID‐19 as well as to outline the impact of the pandemic on patients with headache disorders and headache medicine in clinical practice.
Sarah M Bobker, M. Robbins
semanticscholar +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT This case described a 25‐year‐old pregnant woman with refractory multifocal epilepsy, diagnosed in 2020 and treated with bilateral thalamic deep brain stimulation (DBS) targeting the centromedian and pulvinar nuclei. Prior to DBS, she experienced daily focal seizures, often progressing to generalized tonic–clonic seizures despite optimal ...
Shalin Shah +4 more
wiley +1 more source
Rizatriptan as an Over-the-Counter Triptan in the Treatment of Migraine Attacks
Pain and TherapyAround 91% of migraine patients use over-the-counter medicines to treat attacks, often without further treatment or medical consultation. This therapeutic principle is established in most countries, regardless of how the healthcare system is otherwise ...
Carl H. Göbel +3 more
doaj +1 more source
Case Series of Headache Characteristics in COVID‐19: Headache Can Be an Isolated Symptom
Headache, 2020 Headache was reported in up to one‐third of the hospitalized patients; yet, the clinical characteristics of headache associated with coronavirus disease 2019 (COVID‐19) have not been defined.
Tuğçe Toptan +3 more
semanticscholar +1 more source
Paroxysmal Dyskinesias Secondary to HHV‐6A Encephalitis: The First Case Report and Literature Review
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Paroxysmal dyskinesias encompasses a spectrum of conditions marked by intermittent involuntary movements, with paroxysmal kinesigenic dyskinesias being the most common phenotype. Central nervous system infection is a rare cause of paroxysmal dyskinesias.
Zhuoran Wang +5 more
wiley +1 more source
Trial of Galcanezumab in Prevention of Episodic Cluster Headache.
New England Journal of Medicine, 2019 BACKGROUND Episodic cluster headache is a disabling neurologic disorder that is characterized by daily headache attacks that occur over periods of weeks or months. Galcanezumab, a humanized monoclonal antibody to calcitonin gene-related peptide, may be a
P. Goadsby +12 more
semanticscholar +1 more source